Avalyn Pharma Statistics
NASDAQ: AVLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
28.40-0.30 (-1.05%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Avalyn Pharma by the numbers
Avalyn Pharma has a market capitalization of $1.26 billion based on 44.52M shares outstanding. With trailing EPS of $-3.96, Avalyn Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.7% above its 50-day average and 4.9% below its 200-day average.
Average daily trading volume is 352.95K shares, or about $10.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AVLN valuation vs. peer median
| Metric | AVLN | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.26B | $1.24B | +2% |
| Avg. volume | 352.95K | 1.98M | -82% |
Peer median across 8 companies: LBRX, INVA, MNKD, SLN, GENB, OCUL, NUVB, MLYS.
Valuation
- Market cap
- $1.26B
- EPS (TTM)
- $-3.96
- Shares outstanding
- 44.52M
Price and trading
- Previous close
- 28.70
- Open
- 28.06
- Day range
- 27.85 – 29.38
- 52-week range
- 22.24 – 40.17
- Beta
- —
- Volume
- 214.29K
- Average volume
- 352.95K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 1.26B
- Forward Pe
- -11.01
- Eps
- -3.96
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.17
- Week52 Low
- 22.24
- Avg Volume
- 352.95K
- Shares Outstanding
- 44.52M
- Ma50
- 27.93
- Ma200
- 29.86
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -29.30%
- Pct From52w Low
- 27.70%